NCT05053841View on ClinicalTrials.gov

Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer Women

PHASE2CompletedINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions

MetforminBreast Cancer

Interventions

DRUG

Metformin

All Listed Sponsors

lead

Tanta University

OTHER

NCT05053841 - Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer Women | Biotech Hunter | Biotech Hunter